Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Philibert Goulet"'
Autor:
Denis Sohy, Isabelle Dusart, Philibert Goulet, Diane Visy, Luc Gasthuys, Tatjana Poplazarova, Thomas Breuer, Norman Begg
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 6, Pp 1509-1514 (2018)
Involving patients in the development of medicines and vaccines should result in benefits to patients. The vaccine recipient is usually a healthy person. We describe the rationale and implementation of a vaccine company's initiative to encourage empl
Externí odkaz:
https://doaj.org/article/c5cbc104433f48028a44467d18bd049a
Autor:
Desirée Van Oorschot, Ashleigh McGirr, Philibert Goulet, Patricia Koochaki, Ramya Pratiwadi, Selam Shah, Desmond Curran
Publikováno v:
Infectious diseases and therapy. 11(1)
After a chickenpox infection, the varicella zoster virus lies dormant in nerve cells and can be reactivated in later life to cause herpes zoster (HZ), also called shingles, a painful rash that may result in persistent postherpetic neuralgia (PHN). Tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346b3ec21286822d60a695b3ffb4766f
https://pubmed.ncbi.nlm.nih.gov/34994924
https://pubmed.ncbi.nlm.nih.gov/34994924
Publikováno v:
Vaccine. 40(6)
The European Clinical Trial Regulation No 536/2014 is the first mandate for a non-technical, publicly disclosed, plain language summary (PLS) of clinical trial results. This easy-to-understand summary has the potential to inform the public about clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c55b47e971550339541fe72be03527
https://pubmed.ncbi.nlm.nih.gov/34996640
https://pubmed.ncbi.nlm.nih.gov/34996640
Autor:
Norman Begg, Denis Sohy, Diane Visy, Philibert Goulet, Luc Gasthuys, Tatjana Poplazarova, Isabelle Dusart, Thomas Breuer
Publikováno v:
Human Vaccines & Immunotherapeutics
Involving patients in the development of medicines and vaccines should result in benefits to patients. The vaccine recipient is usually a healthy person. We describe the rationale and implementation of a vaccine company's initiative to encourage empl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27946fd7c568c8455bc8eec977fb6b8d
https://doi.org/10.1080/21645515.2018.1428510
https://doi.org/10.1080/21645515.2018.1428510